DK0460488T3 - Svovlholdige heterocykliske forbindelser - Google Patents

Svovlholdige heterocykliske forbindelser

Info

Publication number
DK0460488T3
DK0460488T3 DK91108581T DK91108581T DK0460488T3 DK 0460488 T3 DK0460488 T3 DK 0460488T3 DK 91108581 T DK91108581 T DK 91108581T DK 91108581 T DK91108581 T DK 91108581T DK 0460488 T3 DK0460488 T3 DK 0460488T3
Authority
DK
Denmark
Prior art keywords
sulfur
containing heterocyclic
heterocyclic compounds
optionally substituted
ring
Prior art date
Application number
DK91108581T
Other languages
Danish (da)
English (en)
Inventor
Takashi Sohda
Iwao Yamazaki
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK0460488T3 publication Critical patent/DK0460488T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655381Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring
    • C07F9/65539Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK91108581T 1990-05-30 1991-05-27 Svovlholdige heterocykliske forbindelser DK0460488T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14194390 1990-05-30

Publications (1)

Publication Number Publication Date
DK0460488T3 true DK0460488T3 (da) 2001-09-17

Family

ID=15303749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91108581T DK0460488T3 (da) 1990-05-30 1991-05-27 Svovlholdige heterocykliske forbindelser

Country Status (8)

Country Link
EP (1) EP0460488B1 (fr)
JP (2) JP2992653B2 (fr)
AT (1) ATE203020T1 (fr)
CA (1) CA2043468A1 (fr)
DE (1) DE69132651T2 (fr)
DK (1) DK0460488T3 (fr)
ES (1) ES2157887T3 (fr)
GR (1) GR3036836T3 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE199721T1 (de) * 1994-07-04 2001-03-15 Takeda Chemical Industries Ltd Phosphonsäure verbindungen imre herstellung und verwendung
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
WO1996039134A1 (fr) * 1995-06-05 1996-12-12 Takeda Chemical Industries, Ltd. Composition pharmaceutique favorisant l'osteogenese
AU6471896A (en) * 1995-07-24 1997-02-18 Takeda Chemical Industries Ltd. Production of optically active benzothiepin salts
AU3868997A (en) * 1996-08-26 1998-03-19 Takeda Chemical Industries Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
AU4571097A (en) * 1996-10-09 1998-05-05 Takeda Chemical Industries Ltd. A method for producing a microparticle
EP1087774A2 (fr) * 1998-06-15 2001-04-04 Takeda Chemical Industries, Ltd. Composition traitant une maladie du cartilage
EP1103552A4 (fr) * 1998-08-07 2003-01-15 Takeda Chemical Industries Ltd Derives de benzothiepine, leur procede de preparation et leurs utilisations
WO2000009100A2 (fr) * 1998-08-12 2000-02-24 Takeda Chemical Industries, Ltd. Renforçateur du facteur d'induction de la differenciation cellulaire
CA2373073A1 (fr) 1999-05-07 2000-11-16 Takeda Chemical Industries, Ltd. Composes cycliques et leurs utilisations
CA2447618A1 (fr) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Composition pour le traitement regeneratif de la maladie du cartilage
MXPA03010679A (es) 2001-05-23 2004-03-02 Tanabe Seiyaku Co Una composicion para acelerar la cicatrizacion de fractura osea.
US20100221345A1 (en) 2006-01-18 2010-09-02 National University Corporation Tokyo Medical And Osteogenic biomaterial containing osteogenesis promoting substance and nanogel
KR102062762B1 (ko) * 2017-10-18 2020-01-06 이경민 반죽을 수제비 형상으로 성형하는 성형장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636049A (en) * 1969-11-26 1972-01-18 Pfizer Isothiochroman carboxamides
DK656789A (da) * 1988-12-28 1990-06-29 Takeda Chemical Industries Ltd Benzoheterocykliske forbindelser

Also Published As

Publication number Publication date
JPH09176154A (ja) 1997-07-08
ES2157887T3 (es) 2001-09-01
EP0460488A1 (fr) 1991-12-11
JP3165889B2 (ja) 2001-05-14
JP2992653B2 (ja) 1999-12-20
DE69132651T2 (de) 2001-10-25
EP0460488B1 (fr) 2001-07-11
DE69132651D1 (de) 2001-08-16
ATE203020T1 (de) 2001-07-15
JPH04364179A (ja) 1992-12-16
GR3036836T3 (en) 2002-01-31
CA2043468A1 (fr) 1991-12-01

Similar Documents

Publication Publication Date Title
NO904377L (no) Tricykliske karbapenemforbindelser.
DK0460488T3 (da) Svovlholdige heterocykliske forbindelser
AU1929088A (en) Polyethylene glycol carbamates
KR970704864A (ko) 세정제 조성물
GB8920521D0 (en) New compositions of matter
DK0479546T3 (da) Piperazinderivater
TW256832B (fr)
DK656789A (da) Benzoheterocykliske forbindelser
DE68922765D1 (de) Substituierte Naphthalen-Verbindungen und diese enthaltende Flüssigkristall-Zusammensetzungen.
AU2321688A (en) Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
EP0538969A3 (fr)
AU4983790A (en) Aralkylamine compounds
PT83334A (en) Process for the preparation of beta-lactam compounds
KR890012929A (ko) 2개의 방향족 환 함유 화합물의 디아실화 방법
GB8830226D0 (en) Novel compounds
DE3867494D1 (de) Fluor enthaltende vitamin-d2-derivate.
EP0609457A4 (en) Benzene derivative.